Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
Pérez-Ríos, Mónica (Instituto de Investigación Sanitaria de Santiago (IDIS))
López-Medina, Diana Carolina (Fundación Carolina)
Guerra-Tort, Carla (Universidade de Santiago de Compostela)
Rey-Brandariz, Julia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Varela-Lema, Leonor (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Santiago-Pérez, María Isolina (Dirección General de Salud Pública. Xunta de Galicia)
Candal, Cristina (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Montes, Agustin (Instituto de Investigación Sanitaria de Santiago (IDIS))
López Medina, María José (Institut d'Investigació Biomèdica Sant Pau)
Dalmau, Regina (Hospital Universitario La Paz (Madrid))
Provencio, Maraino (Hospital Universitario Puerta de Hierro Majadahonda (Madrid))
Fernández, Esteve (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Blanco, Ana (Universidade de Santiago de Compostela)
Ruano-Ravina, Alberto (Instituto de Investigación Sanitaria de Santiago (IDIS))
Universitat Autònoma de Barcelona

Data:	2023
Resum:	Exposure to environmental tobacco smoke (ETS) is associated with increased mortality and morbidity. The objective of this study was to estimate the impact of ETS exposure in Spain on mortality in 2020 in the population aged 35 years and over. A method of estimating attributable mortality (AM) based on the prevalence of ETS exposure was applied. Prevalence data were obtained from a representative study conducted in Spain and the relative risks were derived from a meta-analysis. AM point estimates are presented along with 95% confidence intervals (95% CI), calculated using a bootstrap naive procedure. AM, both overall and by smoking habit, was estimated for each combination of sex, age group, and cause of death (lung cancer and ischemic heart disease). A sensitivity analysis was performed. A total of 747 (95% CI 676-825) deaths were attributable to ETS exposure, of which 279 (95% CI 256-306) were caused by lung cancer, and 468 (95% CI 417-523) by ischemic heart disease. Three-quarters (75. 1%) of AM occurred in men and 60. 9% in non-smokers. When chronic obstructive pulmonary disease and cerebrovascular disease are included, the burden of AM is estimated at 2242 deaths. ETS exposure is associated with 1. 5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. These data underline the need for health authorities to focus on reducing exposure to ETS in all settings and environments.
Ajuts:	Instituto de Salud Carlos III PI22/00727
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Cerebrovascular disease ; Chronic obstructive pulmonary disease ; Ischemic heart disease ; Lung cancer ; Mortality ; Second-hand tobacco smoke
Publicat a:	Archivos de bronconeumologia, Vol. 59 Núm. 5 (may 2023) , p. 305-310, ISSN 1579-2129

DOI: 10.1016/j.arbres.2023.02.017
PMID: 36967344

6 p, 435.2 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats